---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-096021"
form_type: "8-K"
ticker: "OCUL"
cik: "0001393434"
company_name: "OCULAR THERAPEUTIX, INC"
filed_at: "2024-09-03T23:59:59+00:00"
generated_at: "2026-05-31T06:35:46.279300+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Ocular Therapeutix appoints Donald Notman as COO, retains CFO role

## Summary
- Donald Notman, age 65, appointed COO on August 29, 2024; continues as CFO and principal financial and accounting officer.
- Notman has served as CFO since September 2017; prior roles include CFO of Thrasos Therapeutics and Managing Director at Leerink Swann.
- No arrangements or family relationships with other directors/officers; no related party transactions under Item 404(a).

## SEC filing metadata
- accession: 0001104659-24-096021
- form_type: 8-K
- ticker: OCUL
- cik: 0001393434
- company_name: OCULAR THERAPEUTIX, INC
- filed_at: 2024-09-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1393434/000110465924096021/0001104659-24-096021-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1393434/000110465924096021/tm2423106d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-096021
- JSON: https://secwatch.observer/filing/0001104659-24-096021.json
- Plain text: https://secwatch.observer/filing/0001104659-24-096021.txt

## Key facts
- Executive change
  Donald Notman was appointed as Chief Operating Officer at OCULAR THERAPEUTIX, INC.
  - Action: appointed
  - Role: Chief Operating Officer
  source text: On August 29, 2024, the board of directors of Ocular Therapeutix, Inc. (the “Company”) appointed Donald Notman to serve as Chief Operating Officer of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1393434/000110465924096021/0001104659-24-096021-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.